HSA — authorised 20 September 2000
- Marketing authorisation holder: EMD SERONO
- Status: likely_approved
HSA authorised Ovidrel on 20 September 2000
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. HSA authorised it on 20 September 2000.
EMD SERONO holds the Singaporean marketing authorisation.